1. Home
  2. GLDG vs CRVO Comparison

GLDG vs CRVO Comparison

Compare GLDG & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoldMining Inc.

GLDG

GoldMining Inc.

HOLD

Current Price

$0.95

Market Cap

205.6M

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

BUY

Current Price

$4.13

Market Cap

39.3M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
GLDG
CRVO
Founded
2009
2001
Country
Canada
United States
Employees
N/A
15
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.6M
39.3M
IPO Year
2012
2011

Fundamental Metrics

Financial Performance
Metric
GLDG
CRVO
Price
$0.95
$4.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$3.75
$23.00
AVG Volume (30 Days)
2.0M
15.8M
Earning Date
04-10-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,006,510.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$2.13
52 Week High
$2.27
$13.13

Technical Indicators

Market Signals
Indicator
GLDG
CRVO
Relative Strength Index (RSI) 41.36 63.15
Support Level $0.85 $3.92
Resistance Level $1.17 $4.27
Average True Range (ATR) 0.07 0.83
MACD 0.00 0.18
Stochastic Oscillator 33.38 37.15

Price Performance

Historical Comparison
GLDG
CRVO

About GLDG GoldMining Inc.

GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. Its principal projects are the La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; the Sao Jorge Gold Project, located in Brazil; and its interest in the Whistler Gold-Copper Project, located in Alaska, United States. Additionally, the company has several other projects in its portfolio, such as the Yellowknife Gold Project, Cachoeira Gold Project, Surubim Gold Project, Yarumalito Gold Project, Rea Uranium Project, etc. The firm has two operating segments, with U.S. GoldMining as one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: